Table 3: Percentages of the RA patient cohort using prednisolone, DMARDs and bDMARDs.
| Medication information | |
| Medication | Number of RA patients (%) |
| Prednisolone | 37 (43.5%) |
| DMARD | Total: 71 (82.6%) |
| Methotrexate: 58 (67.4%) | |
| Plaquenil: 28 (32.9%) | |
| Sulfasalazine: 18 (21.2%) | |
| Leflunomide: 12 (12.8%) | |
| bDMARD | 32 (37.6%) |